3123.0: Monday, November 13, 2000 - 2:45 PM

Abstract #12730

Report of the IOM Committee on Immunization Finance

Bernard Guyer, MD, MPH, Department of Population and Family Health Sciences, Johns Hopkins School of Public Health, 615 N. Wolfe St, Baltimore, MD 21205, 410-955-3384, bguyer@jhsph.edu

The findings and recommendations of the IOM report on Immunization Finance will be presented, which address six questions posed by the Congress. Specifically, the Committee will report on: (1)the overall level of spending for immunization in the U.S. during the 1990s; (2) how federal funds were spent by the States and to what extent the States maintained their own level of effort over the last 5 years; (3) current and future funding requirements for childhood immunization and how these requirements can be met through a combination of State, federal and State Children’s Health Insurance Program funding; (4) how Federal grants should be distributed among the States; (5) how funds should be targeted within the States to reach high-risk populations; and (6) the national level of effort needed to vaccinate adults and achieve national goals for the influenza and pneumococcal vaccines.

The findings of the Committee derive from the collection and analysis of data from the National Immunization Program at the CDC, a survey of the 50 States, case studies and site visits to a group of selected States and cities, and expert testimony obtained by the Committee. The 15 member committee met over an 18 month period to review these data and reach its final recommendations.

Learning Objectives: 1. The IOM report will present an analysis of how federal immunization funds were distributed in the 1990s 2. State expenditure patterns for vaccine purchase and infrastructure support will be reviewed. 3. New finance approaches for strengthening the federal-state partnership in supporting child and adult immunizations will be considered

Keywords: Financing, Immunizations

Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: Institute of Medicine Centers for Disease Control and Prevention (National Immunization Program) Senate Appropriations Committee
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.

The 128th Annual Meeting of APHA